Jessica A. Shepherd MD, MBA, FACOG, and Mauricio Abrão, MD, share optimal treatment approaches for patients with uterine fibroids and explore the utilization of GnRH antagonists in disease management.
April 11th 2022
Mauricio Abrão, MD, provides an overview of the diagnosis, risk factors, and clinical burden of uterine fibroids.
Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, comment on the use of diagnostic tools and the importance of imaging in approaching the treatment of uterine fibroids.
April 18th 2022
Experts in gynecology discuss factors to consider when approaching the treatment of patients with uterine fibroids and discuss the importance of shared decision-making.
Dr Mauricio Abrão leads a discussion on considerations for selecting the optimal surgical options for patients with uterine fibroids.
April 25th 2022
Drs Mauricio Abrão and Jessica A. Shepherd provide insight on treating fibroids with nonsurgical treatment options for patients.
Experts in gynecology provide an overview of GnRH antagonists and examine the therapeutic use of these agents in treating patients with uterine fibroids.
May 2nd 2022
Jessica A. Shepherd, MD, MBA, FACOG, and Mauricio Abrão, MD, assess the use of FDA-approved GnRH antagonists in clinical practice.
Drs Jessica A. Shepherd and Mauricio Abrão share recommendations for the treatment selection of GnRH antagonists when treating patients with uterine fibroids.
Mauricio Abrão, MD, and Jessica A. Shepherd, MD, MBA, FACOG, address gaps in care for the treatment of uterine fibroids and share the importance of patient education in disease management.